Microcrystalline Cellulose Ingredient Recalled Over Failed Impurity Specifications
DuPont Nutrition USA, Inc. is recalling certain batches of Avicel PH-101 microcrystalline cellulose because it failed quality testing for impurities and degradation. The ingredient showed out-of-specification conductivity levels.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recall with no reported illnesses or injuries. The hazard is a specification failure with potential impurities rather than a confirmed contamination or adverse event, consistent with precautionary low-risk recalls.
Plain-English summary
DuPont Nutrition USA, Inc. is recalling 131,060 kg of Avicel PH-101 NF (microcrystalline cellulose) in polyethylene-lined containers. Microcrystalline cellulose is an ingredient used by pharmaceutical manufacturers in the production of drugs.
The recall was initiated because the product failed quality specification testing. The ingredient showed out-of-specification results for conductivity, indicating the presence of potential impurities or degradation products. This suggests the ingredient may not meet required purity standards.
The affected product batches are: 2173763874, 2173771315, P120834254, P120834263, P120834267, P120834275, P120834441, P120834442, P120834472, P120834507, P120834517, P120834518, P120834519, and P120834520. The product was distributed nationwide in the United States and Puerto Rico and to Australia, China, Canada, Colombia, Mexico, Brazil, Malaysia, Chile, Dominican Republic, Singapore, Thailand, Ireland, Germany, South Korea, Argentina, Pakistan, Oman, and India.
Pharmaceutical manufacturers and distributors who received this ingredient in the affected batches should stop using it and review whether any products they manufactured with this ingredient require recalls or precautionary recalls.
The recalled product
- Product
- Avicel PH- 101 NF, Microcrystalline Cellulose, NF, Ph. Eur., Jp. Net Content/Gross Weight 50.0 KG / 54.5 KG bulk container, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711, USA. Headquarters: DuPont Nutrition Biosciences ApS, Langebrogade 1…
- Manufacturer
- DuPont Nutrition USA, Inc
- Category
- Drug — Pharmaceutical Excipient
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Batch # 2173763874
- 2173771315
- P120834254
- P120834263
- P120834267
- P120834275
- P120834441
- P120834442
- P120834472
- P120834507
- P120834517
- P120834518
- P120834519
- P120834520
- These excipients are noted not to have an expiration date.
Distribution
Part of a larger recall action
This product is one of 4 recalled by DuPont Nutrition USA, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · DuPont Nutrition USA, Inc
See all →- ModerateDuPont Recalls Avicel PH-101 Microcrystalline Cellulose for Out-of-Specification Conductivity
FDA (Drugs) · 2023-05-03
- Moderate
- ModerateDuPont Avicel DG pharmaceutical ingredient recalled for failed quality specification
FDA (Drugs) · 2023-05-03
- LowFDA recalls Avicel PH-102 microcrystalline cellulose bulk ingredient for specification failure
FDA (Drugs) · 2023-05-03
- LowAvicel PH-200 pharmaceutical excipient recalled for failed conductivity specification
FDA (Drugs) · 2023-03-08
Same hazard · impurities
See all →- SevereZydus Recalls Hydrocortisone Sodium Succinate Injection for Impurity Failures
FDA (Drugs) · 2026-10-21
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Specifications
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Failures
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Failures
FDA (Drugs) · 2026-10-14
- ModerateCipla Recalls Fosfomycin Tromethamine Due to Impurity Specification Failures
FDA (Drugs) · 2026-10-14
Similar recalls
- LowFDA recalls Avicel PH-102 microcrystalline cellulose bulk ingredient for specification failure
FDA (Drugs) · 2023-05-03
- ModerateDuPont Recalls Avicel PH-101 Microcrystalline Cellulose for Out-of-Specification Conductivity
FDA (Drugs) · 2023-05-03
- Moderate
- ModerateAvicel Microcrystalline Cellulose Recall for Out-of-Specification Conductivity
FDA (Drugs) · 2021-08-25
- ModerateDuPont Avicel DG pharmaceutical ingredient recalled for failed quality specification
FDA (Drugs) · 2023-05-03
- SevereAvicel RC-591 NF Bulk Powder Recalled for Microbial Contamination
FDA (Drugs) · 2021-09-29